Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy

Therapeutic Apheresis and Dialysis

Volumn 10, Issue 1, 2006, Pages 42-48

  Staudt, Alexander ^a   Staudt, Yvonne ^a   Hummel, Astrid ^a   Empen, Klaus ^a   Dörr, Marcus ^a   Trimpert, Christiane ^a   Birkenmeier, Katrin ^a   Kühl, Uwe ^b   Noutsias, Michel ^b   Russ, Dirk ^a   Felix, Stephan B ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

ANP; BNP; Dilated cardiomyopathy; Immunoadsorption

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; IMMUNOADSORPTION; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOSORBENT TECHNIQUES; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; VENTRICULAR FUNCTION, LEFT;

EID: 33644990245     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2006.00343.x     Document Type: Article

References (36)

1. Richardson P McKenna W Bristow M et al. Report of the 1995 World Health Organization/International society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies Circulation 1996 93 841 2
2. Smith SC Allen PM Myosin-induced acute myocarditis is a T cell mediated disease J Immunol 1991 147 2141 7
3. Schulze K Becker BF Schauer R Schultheiss HP Antibodies to ADP-ATP carrier - an autoantigen in myocarditis and dilated cardiomyopathy - impair cardiac function Circulation 1990 81 959 69
4. Caforio AL Grazzini M Mann JM et al. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy Circulation 1992 85 1734 42
5. Limas CJ Goldenberg IF Limas C Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy Circ Res 1989 64 97 103
6. Magnusson Y Wallukat G Waagstein F Hjalmarson A Hoebeke J Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect Circulation 1994 89 2760 7
7. Fu LX Magnusson Y Bergh CH et al. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy J Clin Invest 1993 91 1964 8
8. Schultheiss HP Kuhl U Janda I Melzner B Ulrich G Morad M Antibody-mediated enhancement of calcium permeability in cardiac myocytes J Exp Med 1988 168 2102 9
9. Nishimura H Okazaki T Tanaka Y et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice Science 2001 291 319 22
10. Okazaki T Tanaka Y Nishio R et al. Autoantibodies against troponin-I are responsible for dilated cardiomyopathy in PD-1 deficient mice Nat Med 2003 9 1477 83
11. Jahns R Boivin V Hein L et al. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy J Clin Invest 2004 113 1419 29
12. Baba A Yoshikawa T Ogawa S Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy J Am Coll Cardiol 2002 40 1153 9
13. Dorffel WV Felix SB Wallukat G et al. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy Circulation 1997 95 1994 7
14. Felix SB Staudt A Dorffel WV et al. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study J Am Coll Cardiol 2000 35 1590 8
15. Muller J Wallukat G Dandel M et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy Circulation 2000 101 385 91
16. Felix SB Staudt A Landsberger M et al. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption J Am Coll Cardiol 2002 39 646 52
17. Staudt A Bohm M Knebel F et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients suffering from dilated cardiomyopathy Circulation 2002 106 2448 53
18. Staudt A Schaper F Stangl V et al. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution Circulation 2001 103 2681 6
19. Staudt A Dorr M Staudt Y et al. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption Am Heart J 2005 150 729 36
20. Francis GS Benedict C Johnstone DE et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD) Circulation 1990 82 1724 9
21. Richards AM Doughty R Nicholls MG et al. Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction Circulation 1999 99 786 92
22. Maeda K Tsutamoto T Wada A et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure J Am Coll Cardiol 2000 36 1587 93
23. Stanek B Frey B Hulsmann M et al. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction J Am Coll Cardiol 2001 38 436 42
24. Davis M Espiner E Richards G et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea Lancet 1994 343 440 4
25. Berger R Strecker K Huelsmann M et al. Prognostic power of neurohumoral parameters in chronic heart failure depends on clinical stage and observation period J Heart Lung Transplant 2003 22 1037 45
26. Riddervold F Smiseth OA Hall C Groves G Risoe C Rate-induced increase in plasma atrial natriuretic factor can occur independently of changes in atrial wall stretch Am J Physiol 1991 260 H1953 8
27. Nishimori T Tsujino M Sato K Imai T Marumo F Hirata Y Dexamethasone-induced up-regulation of adrenomedullin and atrial natriuretic peptide genes in cultured rat ventricular myocytes J Mol Cell Cardiol 1997 29 2125 30
28. Catuzzo B Ciancamerla F Bobbio M Longo M Trevi GP In patients with severe systolic dysfunction, only brain natriuretic peptide is related to diastolic restrictive p[attern J Card Fail 2003 9 303 10
29. Staudt A Staudt Y Dorr M et al. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy J Am Coll Cardiol 2004 44 829 36
30. Johnson W Omland T Hall C et al. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure J Am Coll Cardiol 2002 39 1623 9
31. van Veldhuisen DJ Genth-Zotz S Brouwer J et al. High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril J Am Coll Cardiol 1998 32 1181 8
32. Sanderson JE Chan WW Hung YT et al. Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker Br Heart J 1995 74 502 7
33. Mobini R Staudt A Felix SB et al. Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy J Autoimmun 2003 423 115 19
34. Dwyer J Manipulating the immune system with immune globulin N Engl J Med 1992 326 107 16
35. Gullestad L Aass H Fjeld JG et al. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure Circulation 2001 103 220 5
36. McNamara DM Holubkov R Starling RC et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy Circulation 2001 103 2254 9